Description

9-Benzyl-2,4,9-Triaza-Spiro[5.5]Undec-2-En-3-Ylamine (Wx100263) is a high-purity, advanced pharmaceutical intermediate featuring a unique spirocyclic triaza structure. This compound is critical for the synthesis of complex active pharmaceutical ingredients (APIs) and serves as a versatile building block in modern medicinal chemistry. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of novel therapeutics, particularly in the areas of central nervous system (CNS) and metabolic disease research.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of complex drug candidates and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used in the discovery and optimization of new chemical entities, particularly for CNS-targeting drugs.
• Organic Synthesis: Serves as a versatile precursor for constructing complex nitrogen-containing heterocycles and spirocyclic frameworks.
• Contract Research & Development (CRO/CDMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Employed in university and institutional labs for studying novel synthetic methodologies and structure-activity relationships.

Basic Information

Product Name	9-Benzyl-2,4,9-Triaza-Spiro[5.5]Undec-2-En-3-Ylamine (Wx100263)
CAS No.	1251003-44-7
Molecular Formula	C17H24N4
Molecular Weight	284.40 g/mol
Synonyms	9-Benzyl-2,4,9-triazaspiro[5.5]undec-2-en-3-amine; Wx100263; 2,4,9-Triazaspiro[5.5]undec-2-ene-3-amine, 9-benzyl-; 9-Benzyl-2,4,9-triazaspiro[5.5]undec-2-en-3-ylamine; Benzyltriazaspiroamine; BTAU-3-amine; Spirocyclic triaza amine intermediate
EINECS	Contact for details

Quality Control

Our 9-Benzyl-2,4,9-Triaza-Spiro[5.5]Undec-2-En-3-Ylamine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) are provided with every shipment, detailing all specifications and test results. We adhere to cGMP principles for pharmaceutical intermediates to support our clients' regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.